AB vs CNS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 13, 2026

AB

41.2
AI Score
VS
CNS Wins

CNS

51.9
AI Score

Investment Advisor Scores

AB

41score
Recommendation
HOLD

CNS

52score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric AB CNS Winner
Forward P/E 9.4251 19.084 AB
PEG Ratio 0.6343 1.7476 AB
Revenue Growth -40.3% 12.2% CNS
Earnings Growth 20.9% 31.9% CNS
Tradestie Score 41.2/100 51.9/100 CNS
Profit Margin 390.6% 28.8% AB
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

AB 1M: -1.0% · 3M: -0.9% CNS 1M: -11.6% · 3M: -1.4%

Current Technical Phase

AB

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope 0.4%) with fading momentum, RSI 40

RSI (14): 40.5 · Price: $36.09

CNS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 33

RSI (14): 32.6 · Price: $74.95

Fundamentals Snapshot

Metric AB CNS
Market Cap
Forward P/E 9.4 18.8
Trailing P/E 10.9 23.7
Revenue (TTM)
Revenue Growth -0.4% 0.1%
Gross Margin 1.0% 0.5%
Operating Margin 1.0% 0.3%
EPS 3.35 3.23
Dividend Yield 0.10% 0.03%

Frequently Asked Questions

Based on our detailed analysis, CNS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.